REAL-WORLD SAFETY AND EFFICACY OF USTEKINUMAB AND VEDOLIZUMAB IN PEDIATRIC PATIENTS WITH INFLAMMATORY BOWEL DISEASE

被引：0
|
作者：
Hsu, Diane
Lee, Justin
Kotzen, Alison
Bensen, Rachel
Goyal, Alka
机构：
来源：
INFLAMMATORY BOWEL DISEASES | 2024年 / 30卷
关键词：
D O I：
10.1093/ibd/izae020.159
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
izae020.15
引用
收藏
页码：S73 / S74
页数：2
相关论文
共 50 条
  • [41] Effectiveness and safety of vedolizumab in real-world studies in Asian patients with inflammatory bowel disease: a systematic review and meta-analysis
    Gu, Y.
    Zhang, X.
    Gu, L.
    Zou, D.
    JOURNAL OF CROHNS & COLITIS, 2025, 19 : i1969 - i1971
  • [42] Safety and Efficacy of Biologic Therapies (Ustekinumab and Vedolizumab) in the Treatment of Inflammatory Bowel Disease (IBD): A Systematic Review
    Ashraf, Hafsa
    Bodapati, Adiprasad
    Hanif, Ayesha
    Okafor, Donatus K.
    Katyal, Gitika
    Kaur, Gursharan
    Khan, Safeera
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (11)
  • [43] Comparative Safety of Ustekinumab and Vedolizumab in Older Patients with Inflammatory Bowel Disease: A Bicentric Cohort Study
    Burgevin, Alice
    Caron, Benedicte
    Sasson, Alexa
    Luc, Amandine
    Netter, Patrick
    Baumann, Cedric
    Ananthakrishnan, Ashwin N.
    Peyrin-Biroulet, Laurent
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (23)
  • [44] Real-world data on switching from intravenous to subcutaneous vedolizumab treatment in patients with inflammatory bowel disease
    Bergqvist, Viktoria
    Holmgren, Johanna
    Klintman, Daniel
    Marsal, Jan
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2022, 55 (11) : 1389 - 1401
  • [45] Real-World Effectiveness of Vedolizumab Dose Escalation in Patients With Inflammatory Bowel Disease: A Systematic Literature Review
    Patel, Dipen
    Martin, Stephan
    Luo, Michelle
    Ursos, Lyann
    Lirio, Richard A.
    Kamble, Pravin
    Wang, Song
    CROHNS & COLITIS 360, 2022, 4 (03)
  • [46] Ustekinumab and Vedolizumab Safety and Clearance in Pregnancy With Inflammatory Bowel Disease: Stop the Disease, Not the Drug!
    Torres, Joana
    Mahadevan, Uma
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2025, 23 (01) : 28 - 30
  • [47] Safety of Vedolizumab in Inflammatory Bowel Disease Patients: Real World Experience From a Large University Practice
    Ladd, Antonio H. Mendoza
    Scott, Frank I.
    Grace, Rory
    Bownik, Hillary
    Lichtenstein, Gary R.
    GASTROENTEROLOGY, 2016, 150 (04) : S977 - S977
  • [48] Vedolizumab clearance as a predictor of remission in inflammatory bowel disease: a real-world pharmacokinetic study
    Markovic, S.
    Kralj, D.
    Ivanovski, T. Knezevic
    Kalaba, A.
    Odanovic, O.
    Homsek, A.
    Svorcan, P.
    Vucicevic, K.
    JOURNAL OF CROHNS & COLITIS, 2025, 19 : I1231 - I1231
  • [49] Efficacy and safety of biosimilar versus originator infliximab in patients with inflammatory bowel disease: A real-world cohort analysis
    Peeyush Kumar
    Sudheer K. Vuyyuru
    Bhaskar Kante
    Saurabh Kedia
    Pabitra Sahu
    Mukesh Kumar Ranjan
    Sandeep Mundhra
    Rithvik Golla
    Mukesh Kumar
    Shubi Virmani
    Anvita Gupta
    Nidhi Yadav
    Govind Makharia
    Vineet Ahuja
    Indian Journal of Gastroenterology, 2022, 41 : 446 - 455
  • [50] Efficacy and safety of biosimilar versus originator infliximab in patients with inflammatory bowel disease: A real-world cohort analysis
    Kumar, Peeyush
    Vuyyuru, Sudheer K.
    Kante, Bhaskar
    Kedia, Saurabh
    Sahu, Pabitra
    Ranjan, Mukesh Kumar
    Mundhra, Sandeep
    Golla, Rithvik
    Kumar, Mukesh
    Virmani, Shubi
    Gupta, Anvita
    Yadav, Nidhi
    Makharia, Govind
    Ahuja, Vineet
    INDIAN JOURNAL OF GASTROENTEROLOGY, 2022, 41 (05) : 446 - 455
12345